SKKU-SOM Headlines

    • home
    • SKKU-SOM Headlines

SKKU-SOM Headlines

NEWS

Àǰú´ëÇÐ 4´Ü°è BK21»ç¾÷ ÃÖÁ¾¼±Á¤


¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐÀº 4´Ü°è BK21»ç¾÷¿¡ ÃÖÁ¾¼±Á¤µÇ¾ú´Ù. BK21 »ç¾÷Àº ¹Ì·¡ ±¹°¡°æÀï·Â Á¦°í¸¦ À§ÇÑ ¿ì¼ö ´ëÇпø ¿ª·® °­È­ ¹× Çй®ÈļӼ¼´ë ¾ç¼ºÀ» ¸ñÇ¥·Î ¿¬±¸Àç´Ü°ú ±³À°ºÎ°¡ ÃßÁøÇÏ´Â »ç¾÷À¸·Î, ¿ÃÇØ 4´Ü°è¿¡ Á¢¾îµé¾ú´Ù. ƯÈ÷, ±âÃÊÀÇÇÐºÐ¾ß BK FOUR»ç¾÷¿¡´Â Àü±¹´ÜÀ§¿¡¼­ ÃÑ 5°³ ±³À°¿¬±¸´ÜÀÌ ÃÖÁ¾ ¼±Á¤µÇ¾ú´Ù. ±× °¡¿îµ¥ ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐÀÌ ¼±Á¤µÊÀ¸·Î½á, ÇâÈÄ 7³â°£ ÃÑ 70¾ïÀÇ ¿¹»êÀ» Áö¿ø¹Þ¾Æ ¿ì¼ö ´ëÇпø»ý ¹× ½ÅÁø¿¬±¸ÀηÂÀ» Áö¿øÇÒ ¿¹Á¤ÀÌ´Ù.
¿¬±¸´Ü¸íÀº Â÷¼¼´ë Á¤¹ÐÀÇÇÐ ±Û·Î¹ú ±³À°¿¬±¸´ÜÀÌ¸ç ´ÜÀåÀº ±è°æ±Ô ±³¼öÀÌ´Ù. ¿¬±¸´ÜÀº ÁÖ¿ä ±³À° ¸ñÇ¥·Î ¡ã ±³À°: ±Û·Î¹ú ¼±Áø ´ëÇпø ±³À°½Ã½ºÅÛ È®º¸¸¦ ÅëÇÑ Çõ½ÅÀÎÀç¾ç¼º ¡ã ¿¬±¸: 4Â÷»ê¾÷ Á¤¹ÐÀÇÇРƯ¼ºÈ­¸¦ ÅëÇÑ »çȸ°¡Ä¡½ÇÇö âÀÇ¿¬±¸¼º°ú âÃâ ¡ã ±¹Á¦È­ :±Û·Î¹ú À̽´¸¦ ¼±µµÇÏ´Â ±¹Á¦±³À°¿¬±¸ Çãºê ±¸Ãà ¡ã »çȸ°øÇå: º¸°ÇÀÇ·á»çȸ ¹ßÀüÀ» À§ÇÑ ¿¬±¸°á°úÀÇ »çȸȯ¿ø ¹× °¡Ä¡Ã¢ÃâÀ» ³»¼¼¿ü´Ù.

 

 

 

PEOPLE

Á¤Çذü ±³¼ö, Çï·¹½ºÆùÆ®-´Ù¸£´Ù³Ú½ºÇØÇù Ⱦ´Ü ¼ö¿µ´ëȸ Âü°¡±â

2022³â 8¿ù 30ÀÏ ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ ¸í¿¹±³¼öÀÎ Á¤Çذü ±³¼ö°¡ ÅÍŰÀÇ Çï·¹½ºÆùÆ® - ´Ù¸£´Ù³Ú½ºÇØÇù Ⱦ´Ü ¼ö¿µ´ëȸ¿¡ Âü°¡ÇÏ¿© ¼º°øÀûÀ¸·Î ÇØÇùÀ» Ⱦ´ÜÇÏ¿´´Ù. Á¤Çذü ±³¼ö´Â »çȸÀÇÇб³½Ç¿¡¼­ ȯ°æ¿ªÇÐ ºÐ¾ßÀÇ ±³À°°ú ¿¬±¸È°µ¿À» ÇÏ¿´À¸¸ç , ¿ÃÇØ 65¼¼·Î ±Ý³â 8¿ù Á¤³âÅðÀÓÀ» ÇÏ¿´´Ù. 60´ë Áß¹ÝÀÇ ³ªÀÌ¿¡ Äè°Å¸¦ ÀÌ·é Á¤Çذü ±³¼ö¿Í ¼­¸é ÀÎÅͺäÇÑ ³»¿ëÀ» ¾Æ·¡¿¡ ½Æ´Â´Ù.


¡á Äè°Å¸¦ ÃàÇϵ帰´Ù. ¸ÕÀú Âü¿©ÇÏ¿´´ø ÇØÇù Ⱦ´Ü ¼ö¿µ´ëȸ¿¡ ´ëÇØ ¼Ò°³¸¦ ºÎŹÇÑ´Ù.
ÅÍŰ¿¡´Â ´ë·úÀ» °¡¸£´Â µÎ °³ÀÇ À¯¸íÇÑ ÇØÇùÀÌ ÀÖÀ¸¸ç, ¿©±â¼­ ¸Å³â ¿©¸§ Ⱦ´Ü ¼ö¿µ´ëȸ°¡ ¿­¸°´Ù. º¸½ºÆ÷·ç½ºÇØÇù Ⱦ´Ü ¼ö¿µ´ëȸ´Â 34³âÀÇ ¿ª»ç¸¦ °¡Áö°í ÀÖÀ¸¸ç 10¿©³âÀüºÎÅÍ »ï¼ºÀÌ ÇùÂùÇÏ¿© »ï¼º - º¸½ºÆ÷·ç½ºÇØÇù ´ëȸ·Î ºÒ¸®°í ÀÖ´Ù. Çï·¹½ºÆùÆ® - ´Ù¸£´Ù³Ú½ºÇØÇù Ⱦ´Ü ¼ö¿µ´ëȸ´Â 35³âÀÇ ¿ª»ç¸¦ ÀÚ¶ûÇϸç Âü°¡ ±Ô¸ð ¸é¿¡¼­ º¸½ºÆ÷·ç½º ÇØÇù ´ëȸº¸´Ù ´Ù¼Ò ÀÛÁö¸¸ Æ®·ÎÀ̸¦ ºñ·ÔÇÑ °í´ë·ÎºÎÅÍ Çö´ë¿¡ À̸£±â±îÁö ¿ª»çÀûÀ¸·Î Áß¿äÇÑ Áö¿ªÀ̰í, ÃÖÃÊÀÇ ÇØÇù ¼ö¿µÈ¾´Ü±â·ÏÀÌ ÀÖ´Â À¯¼­ ±íÀº ´ëȸ·Î ¸Å³â 8¿ù 30ÀÏ °³Ãֵǰí ÀÖ´Ù. Á÷¼±°Å¸®´Â 3.5 km Á¤µµÀ̳ª ½ÇÁ¦ ¼ö¿µ°Å¸®´Â 5 km¸¦ Á» ³Ñ´Â´Ù .

¡á ¿Ö ÀÌ·± ´ëȸ¿¡ Âü¿©ÇÏ°Ô µÇ¾ú´Â°¡ ?
¾î¸± ¶§ºÎÅÍ ¿©¸§ÀÌ¸é ´Ã °³¿ï¿¡¼­ ¹°³îÀ̸¦ Çϸ鼭 ¹°°ú °¡±îÀÌ ÇÏ¿´´Âµ¥ 50´ë¿¡ µé¾î ¹Ù´Ù¼ö¿µÀÇ ²ÞÀ¸·Î ¹ßÀüÇß´ø °Í °°´Ù. ´©±¸³ª ÀλýÀÇ ¹öŶ ¸®½ºÆ®°¡ Àִµ¥ ³»°Ô´Â º¸½ºÆ÷·ç½º ÇØÇù Ⱦ´Ü ¼ö¿µÀ» ²Þ²Ù¾ú´Ù. Á¤³âÀ» ¸ÂÀ¸¸é¼­ ÇØÇùȾ´ÜÀ» ÇϰíÀÚ ÇÏ¿´À¸³ª º¸½ºÆ÷·ç½º´Â ÀÌ¹Ì µî·ÏÀÌ ³¡³ª ´Ù¸¥ ÇØÇù Ⱦ´Ü ¼ö¿µ´ëȸ°¡ ÀÖÀ½À» ¾Ë°í Âü°¡ÇÏ°Ô µÇ¾ú´Ù.

¡á ¾î¶² ½ÄÀ¸·Î Áغñ¸¦ ÇÏ¿´´ÂÁö ?
¹Ù´Ù ¼ö¿µÀº °³¿ïÀ̳ª ¼ö¿µÀå°ú´Â Á¶°ÇÀÌ ´Ù¸£°í, ÈûµéÁö¸¸ Áñ°Å¿ò°ú º¸¶÷µµ Å©´Ù. ¿ì¼± ÆÄµµ°¡ ÀÖ°í, ½Ã¾ßµµ È帱 ¼ö ÀÖÀ¸¸ç, ÇØ·ù¿¡ ÈÖ¸»·Á Á¶³­´çÇϰųª ÇØÆÄ¸®¿¡ ½îÀÌ¸é ¼îÅ©¿¡ ºüÁú ¼öµµ ÀÖ´Ù. 40 ´ë Á߹ݿ¡ óÀ½À¸·Î ¼ö¿µÀ» Á¤½ÄÀ¸·Î ¹è¿ü°í, 50´ëºÎÅÍ´Â ±¹³» ¹Ù´Ù¼ö¿µ´ëȸ¿¡ °¡²û¾¿ Âü¿©Çϸ鼭 °æÇèÀ» ½×¾Ò´Ù. ¼ö¿µÀ» 6³â ÀÌ»ó ½¬¾ú´Ù°¡ ´ëȸ Âü°¡ 6°³¿ùÀüºÎÅÍ º»°ÝÀûÀÎ °³ÀÎÈÆ·ÃÀ» ÇÏ¿´°í, ÁÖ 1ȸ öÀÎ 3Á¾ °æ±â Âü¿© °æÇèÀÌ ÀÖ´Â ¼±»ý´ÔÀ» ¸ð½Ã°í °³ÀÎ °­½Àµµ ¹Þ¾Ò´Ù. ÃÖ±Ù 6°³¿ù ÈÆ·Ã±â°£ Áß ÁÖÆÄÇÑ °Å¸®°¡ 190 km Âë µÈ´Ù.

¡á ´çÀÏ ÇØÇù ¼ö¿µÀ» Çϸ鼭 ¾î¶² ³­°üÀ» °Þ¾ú´ÂÁö ?
ºü¸¥ Á¶·ù¸¦ Ÿ°í ·çÆ®¸¦ ã´Â °ÍÀÌ °ü°ÇÀε¥ ½Ã¾ß°¡ Èå·Á Áß°£ ¸ñÇ¥·Î »ï¾Æ¾ß ÇÏ´Â ·£µå¸¶Å©°¡ Àß º¸ÀÌÁö ¾Ê¾Æ Á¦´ë·Î °¡°í ÀÖ´ÂÁö È®ÀÎÇϱ⠾î·Á¿ü´Ù. °á½Â ÁöÁ¡¿¡ ÀÓ¹ÚÇØ¼­´Â ¿ªÁ¶·ù¸¦ ¸¸³ª ¾ÕÀ¸·Î ³ª°¡±â°¡ ¸¹ÀÌ Èûµé¾ú´Ù. ±×·² ¶§¸¶´Ù µÎ·Á¿òÀÌ ¾ö½ÀÇßÁö¸¸ ¸Å ½ºÆ®·ÎÅ© ¸¶´Ù È®½ÇÈ÷ ¹°À» Àâ°í ±Û¶óÀ̵ùÀ» ±æ°Ô Çϸ鼭 ¸¶À½ÀÇ ¿©À¯¸¦ °¡Áö·Á°í ÇÏ¿´´Ù. ªÁö ¾ÊÀº °Å¸®¿´À¸³ª Áñ°Å¿î ¸¶À½À¸·Î ¼ö¿µÇÏ¿´°í, ¸¶Ä£ ÈÄ Ã¼·Â¼Ò¸ðµµ ±×¸® ½ÉÇÏÁö ¾Ê¾Ò´Ù.

¡á ÈĹèµé¿¡°Ô ³²±â°í ½ÍÀº À̾߱â´Â ?
´©±¸¿¡°Ô³ª ÀÚ½ÅÀÌ °Ç³Ê¾ß ÇÒ ÇØÇùÀÌ ÀÖ½À´Ï´Ù. ¾î·Æ°í µÎ·Á¿òÀÌ ¾Õ¼³ ¼ö ÀÖÁö¸¸ ÀÚ½ÅÀ» Àß ¾Ë±â À§ÇØ ³ë·ÂÇÏ°í ²ÙÁØÈ÷ ÁغñÇϰí, ³ª¾Æ°¡¸é ÀÚ½ÅÀÇ ÇØÇùÀ» ¹«»çÈ÷ °Ç³Ê°¥ ¼ö ÀÖÀ» °ÍÀÔ´Ï´Ù. ÀúÀÇ ÀλýÀÇ °¡Àå ºû³ª´Â ½Ã±â¸¦ º¸³¾ ¼ö ÀÖ¾ú°í, ¸¹Àº »ç¶ûÀ» ¹Þ¾Ò´ø Àǰú´ëÇп¡ ¸¶À½À¸·ÎºÎÅÍ °¨»çµå¸®¸ç ¼º±Õ°¡Á· ¿©·¯ºÐÀÇ °Ç½ÂÀ» ±â¿øÇÕ´Ï´Ù.

 

 

 

EDUCATION

2022Çг⵵ 2Çб⠴ëÇпø Çо÷ ¿ì¼ö ÀÎÁõ¼­ ¼ö¿©½Ä


2022³â 9¿ù 20ÀÏ (È­) 16:45 Àǰú´ëÇÐ ÇÐÀå½Ç¿¡¼­ ¡®±âÃÊÀÇÇдëÇпø ¿ì¼ö¿¬±¸»ó(Certificate of Academic Excellence Graduate School of Basic Medical Science)¡¯ ¼ö»ó½ÄÀÌ ÁøÇàµÇ¾ú´Ù.

À̳¯ Çà»ç¿¡´Â ÀÌÁÖÈï ÇÐÀå, ¾ÈÁøÇö ±âÃʺÎÀå, ±è°æ±Ô ´ëÇпø ÇаúÀå, À̱⿵ ±³¼ö¿Í ¼ö»óÀÚÀÎ ±èÁö¿µ Çлý(¼®¹ÚÅëÇÕ 4Çбâ, Áöµµ±³¼ö: À̱⿵ ±³¼ö), ¼ÕÁÖÈñ Çлý(¼®¹ÚÅëÇÕ 8±â, Áöµµ±³¼ö: À̱⿵ ±³¼ö)ÀÌ Âü¿©ÇÏ¿´´Ù. ÀÌÁÖÈï ÇÐÀåÀÌ ¼ö»óÀÚ¸¦ ÃàÇÏÇÏ°í °Ý·ÁÇØ ÁÖ¾ú´Ù.

¼º±Õ°ü´ëÇб³ ±âÃÊÀÇÇдëÇпø ¹× BK21 FOUR ¿¬±¸´Ü¿¡¼­´Â ¸Å Çб⠿ì¼öÇÑ ¿¬±¸°á°ú¸¦ ¹ßÇ¥ÇÑ ´ëÇпø»ý¿¡°Ô º» »óÀ» ½Ã»óÇϰí BK ´ëÇпø Çõ½Å ÀåÇбÝÀ» ÁöºÒÇÏ¿© ¿ì¼ö¿¬±¸¾÷ÀûÀ» °Ý·ÁÇϰí ÀÖ´Ù.

 

 

STUDENTS

Àǰú´ëÇÐ Çлý¿¬±¸ ÇÁ·Î±×·¥ Á¦2ȸ à÷ì¢ÇмúÁ¦ ¼º·á
Àǰú´ëÇÐ(ÇÐÀå ÀÌÁÖÈï)¿¡¼­ ÁÖ°üÇÑ <Á¦2ȸ à÷ì¢ÇмúÁ¦>°¡ ¼ºÈ²¸®¿¡ ¸¶¹«¸®µÇ¾ú´Ù.


à÷ì¢ÇмúÁ¦´Â ¿ì¸® Àǰú´ëÇп¡¼­ ½ÃÇàÇÏ´Â Çлý¿¬±¸ ÇÁ·Î±×·¥À¸·Î, ¿¬±¸¿ª·®°ú °úÇÐÀû Á¢±Ù ½Ã°¢À» °®Ãá ¹Ì·¡ÀǰúÇÐÀÚ ¾ç¼º ¹× Çлý¼º°ø °­È­¸¦ À§ÇÏ¿© 2020Çг⵵ºÎÅÍ ½ÃÇàµÇ¾ú´Ù. 2021Çг⵵ Á¦1ȸ ÇмúÁ¦¿¡ ³í¹® ÃÊ·ÏÀ» ¹ßÇ¥ÇÑ Çлý Áß 4¸íÀÇ ÇлýÀº SCI±Þ ÇмúÁö¿¡ Á¦1ÀúÀÚ·Î ³í¹®À» °ÔÀçÇϱ⵵ ÇÏ¿´´Ù.

À̹ø ÇÁ·Î±×·¥¿¡´Â ÀÇÇаú 3Çгâ 51¸íÀÇ ÀçÇлý Àü¿øÀÌ Âü°¡ÇÏ¿´°í, 2.9(¼ö)~2.10(¸ñ) 2ÀÏ °£ ÀÓ»ó±³À°Àå º¹µµ¿¡ ÇлýµéÀÇ ¿¬±¸ ÃÊ·Ï Æ÷½ºÅ͸¦ °ÔÀçÇÏ¿´°í 2.11(±Ý)¿¡´Â ÇлýµéÀÇ 1³â°£ÀÇ ¿¬±¸ °á°ú¸¦ ¹ßÇ¥ÇÏ°í ½Ã»óÇÏ´Â ½ÉÆ÷Áö¾öÀÌ °³ÃֵǾú´Ù.



 

 

½Ã»ó½ÄÀº 2¿ù 11ÀÏ(±Ý) ÀÓ»ó±³À°Àå È÷Æ÷Å©¶óÅ×½ºÈ¦¿¡¼­ ¼ö»óÀÚ¸¸ Âü°¡ÇÑ °¡¿îµ¥ °³ÃֵǾú´Ù. 51¸í Áß 20¸íÀÌ ´ÙÀ½°ú °°ÀÌ ¼ö»óÇÏ°Ô µÇ¾ú´Ù.

¼º¸í ¼ö»ó Áöµµ±³¼ö ¿¬±¸Á¦¸ñ
¹ÚÂùÈñ ´ë»ó °­¿ø¼® henotypic Characterization of MAIT cells in Patients with Advanced Stage Hepatocellular Carcinoma Treated with Lenvatinib
¼­³²ÁÖ ±Ý»ó ¿À¼ö¿µ Supervised gestational diabetes mellitus vs. obesity: which is worse?
Çѵ¿ÈÆ ±Ý»ó Á¶ÁøÈ¯ Association of daily exercise pattern with motor symptoms, non-motor symptoms, and quality of life in Parkinson¡¯s disease
ÁøÇö ±Ý»ó À̰æÇÑ Prognostic value of metabolic bulk volume and other volumetric parameters on FDG PET/CT in diffuse large B-cell lymphoma patients
Á¤ÀÇÂù Àº»ó ÀÌÈ£¿¬ Predicting Postoperative Lung Function Using Quantification on Dual Energy CT before Lobectomy or Pneumonectomy in Lung Cancer Patients
Á¶¹Î±Ù Àº»ó À̹οì Complications after Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Incidence and Risk Factors
°ûÇü¼­ Àº»ó ÀüÈ«Áø Predicting decline of cognitive function in elderly depressed patients through brain imaging
Á¶¼Òºó Àº»ó ¹ÚÅÃ±Ô Ticagrelor/Prasugrel versus Clopidogrel in Patients Undergoing Veno-arterial Extracorporeal Membrane Oxygenation with Acute Myocardial Infarction Complicated by Cardiogenic Shock
È«¼Ò¿µ Àº»ó À±°æÀç Impact of Estrogen Loss on Sarcopenia in Ovariectomized rats with regard to Inflammation, Mitochondrial Dysfunction and Autophagy
±èÈ£¿µ Àº»ó ±è¼º¸ñ The Effectiveness of Coronary Aorta CT Protocol in Management of Coronary Artery Disease and Clinical Outcome in Patients with Aortic Aneurysm.
Á¤À¯Áø µ¿»ó À¯Àç¹Î Long-term oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Samsung medical center.
ÀºÇü¿ì µ¿»ó Á¶´ö Anti-Tumor Effect of Expanded Natural Killer Cells against Bladder Cancer Cells
¹Ú¿ë¿ì µ¿»ó ¹Ú¼ºÀ± Changes in Concordance of Prostate Cancer Grade between Biopsy and Surgery before and after Prostate Imaging Reporting and Data System Version 2/2.1 Release: A Single, Tertiary Institutional Observation
Á¶¼­¹Î µ¿»ó ½ÅÁ¤Èñ Comparison of Clinicopathological Characteristics and Survival Between Symptomatic and Asymptomatic Anaplastic Thyroid Carcinoma
¹ÚŽе¿»ó À¯°æÈ£ Comparison of Hypnotic Potency between Sevoflurane and Desflurane at Equivalent Minimum Alveolar Concentration Using Patient State Index : A Randomized Controlled Trial
±èµµ¿µ µ¿»ó Àü°æ¸¸ Impact of duration of corticosteroid treatment for postoperative acute lung injury after lung cancer surgery
¹é¼ÛÀÍ µ¿»ó ¹ÎÁÖÈ« Association of Neutrophil-to-lymphocyte ratio (NLR) and other novel parameter with disease activity in Myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD)
ÀÌ¿µÇö µ¿»ó À强¾Æ Association between CT calcification patterns and clinical manifestation after pericardiectomy for constrictive pericarditis
À±Çö½Ä µ¿»ó ÀÌÁÖ»ó Identifying the role of TLR in the response to cancer immunotherapy
±è°­¹Î µ¿»ó ÇãÈñÀç Accuracy of Revised Critical Concentration for MGIT Drug Susceptibility Testing of Rifampicin

Çлý¿¬±¸ ÇÁ·Î±×·¥¿¡ Âü°¡ÇÑ ¸ðµç ÇлýµéÀº 2022Çг⵵ ÇÁ·Î±×·¥ ±â¹Ý ÀåÇбÝÀ» ¼öÇý¹ÞÀ» ¿¹Á¤ÀÌ´Ù. 2023Çг⵵¿¡µµ ÀÌ ÇÁ·Î±×·¥Àº ÁøÇàµÉ °èȹÀÌ´Ù.